This product is not anhydrous. The maximum allowable water content is 0.5%. Currently, an anhydrous triethylamine product is not available.
900632
Triethylamine
ZerO2®, ≥99%
Synonym(s):
Degassed and low oxygen triethylamine, Triethylamine ZerO2®, N,N-Diethylethanamine
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
(C2H5)3N
CAS Number:
Molecular Weight:
101.19
Beilstein:
605283
EC Number:
MDL number:
UNSPSC Code:
12352116
NACRES:
NA.21
grade:
ZerO2®
Assay:
≥99%
bp:
88.8 °C (lit.)
vapor pressure:
51.75 mmHg ( 20 °C)
Pricing and availability is not currently available.
Recommended Products
grade
ZerO2®
Quality Level
vapor density
3.5 (vs air)
vapor pressure
51.75 mmHg ( 20 °C)
Assay
≥99%
form
liquid
autoignition temp.
593 °F
expl. lim.
8 %
impurities
≤0.5% water
water
refractive index
n20/D 1.401 (lit.)
pH
12.7 (15 °C, 100 g/L)
bp
88.8 °C (lit.)
mp
−115 °C (lit.)
density
0.726 g/mL at 25 °C (lit.)
SMILES string
CCN(CC)CC
InChI
1S/C6H15N/c1-4-7(5-2)6-3/h4-6H2,1-3H3
InChI key
ZMANZCXQSJIPKH-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Application
ZerO2 products are rigorously degassed with highly pure inert gas providing solvents and solutions (anhydrous if specified) with very low residual oxygen content.
Legal Information
ZerO2 is a registered trademark of Sigma-Aldrich Co. LLC
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1A - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
3 - Flammable liquids
WGK
WGK 1
Flash Point(F)
12.2 °F - closed cup
Flash Point(C)
-11 °C - closed cup
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Eva Hobeika et al.
BMC pharmacology & toxicology, 21(1), 15-15 (2020-02-24)
In developing countries, brand-generic substitution is not based on validated scientific evidence that confirm the therapeutic equivalence of the generic to the originator. Rather, decisions are made based on the availability of generic medications. Substitution by inappropriate preparations applies to
-
Is it anhydrous?
1 answer-
Helpful?
-
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
